# A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 2

> **NCT01596725** · PHASE1 · COMPLETED · sponsor: **Novavax** · enrollment: 333 (actual)

## Conditions studied

- Influenza (Pandemic)

## Interventions

- **BIOLOGICAL:** Monovalent Avian Influenza VLP (H5N1)
- **BIOLOGICAL:** Monovalent Avian Influenza VLP (H5N1)
- **BIOLOGICAL:** Monovalent Avian Influenza VLP (H5N1); Adjuvant
- **BIOLOGICAL:** Monovalent Avian Influenza VLP (H5N1); Adjuvant
- **BIOLOGICAL:** Monovalent Avian Influenza VLP (H5N1); Adjuvant
- **BIOLOGICAL:** Saline Placebo

## Key facts

- **NCT ID:** NCT01596725
- **Lead sponsor:** Novavax
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2012-08
- **Final completion:** 2013-08
- **Target enrollment:** 333 (ACTUAL)
- **Last updated:** 2014-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01596725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01596725, "A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 2". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01596725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*